發(fā)布時(shí)間：2018-05-09 22:43

  本文選題：Lamiken-R宮頸擴(kuò)張棒 + 宮頸擴(kuò)張　； 參考：《中國婦產(chǎn)科臨床雜志》2017年04期

【摘要】：目的探討Lamiken-R宮頸擴(kuò)張棒用于宮腔手術(shù)前擴(kuò)張宮頸的臨床療效及副作用。方法選擇宮內(nèi)節(jié)育器、妊娠10周內(nèi)負(fù)壓吸引人工流產(chǎn)術(shù)、宮腔鏡檢查及手術(shù)的患者130例,抽簽法隨機(jī)分為兩組,研究組(63例)術(shù)前1~2 h宮頸內(nèi)口放置Lamiken-R宮頸擴(kuò)張棒;對照組(67例)術(shù)前3 h于陰道后穹隆放置米索前列醇0.4 mg。以宮頸無阻力通過Hegar宮頸擴(kuò)張棒的號碼評估宮頸松弛程度,觀察兩組宮頸擴(kuò)張效果及副反應(yīng)。結(jié)果研究組成功置入60例,成功率95.2%(60/63);研究組育齡非孕期通過宮頸擴(kuò)張棒的號碼為(8.07±0.73)號,對照組為(6.39±0.93)號;研究組絕經(jīng)期通過宮頸擴(kuò)張棒的號碼為(7.47±0.74)號,對照組為(5.00±0.82)號;研究組妊娠早期通過宮頸擴(kuò)張棒的號碼為(7.85±0.63)號,對照組為(5.95±0.89)號;研究組宮頸擴(kuò)張效果優(yōu)于對照組(P0.01)。研究組發(fā)生惡心嘔吐、腹痛、腹瀉、陰道出血及發(fā)熱率明顯低于對照組(P0.01);兩組術(shù)后體溫正常,無一例發(fā)生感染。結(jié)論 Lamiken-R宮頸擴(kuò)張棒用于宮腔手術(shù)前擴(kuò)張宮頸效果顯著,不良反應(yīng)少,優(yōu)于傳統(tǒng)的米索前列醇,對女性不同時(shí)期擴(kuò)張宮頸口均有效,值得臨床推廣應(yīng)用。
[Abstract]:Objective to investigate the clinical efficacy and side effects of Lamiken-R dilatator for cervical dilatation before intrauterine surgery. Methods 130 patients with intrauterine device, suction induced abortion under negative pressure in 10 weeks of pregnancy, hysteroscopy and operation were randomly divided into two groups: study group (n = 63) and cervical dilatation rod (Lamiken-R) was placed at the intrauterine orifice 1 hour before operation. In the control group (67 cases), 0.4 mg of misoprostol was placed in the posterior vagina fornix 3 h before operation. The degree of cervix relaxation was evaluated by the number of cervical dilatator Hegar without cervical resistance, and the effect and side effects of cervical dilatation were observed. Results 60 cases were successfully implanted in the study group, the success rate was 95.2um 60 / 63, the number of cervical dilatator was 8.07 鹵0.73) in the study group and 6.39 鹵0.93 in the control group, and the number of the cervical dilatator was 7.47 鹵0.74 in the study group and 5.00 鹵0.82 in the control group. The number of cervical dilatator was 7.85 鹵0.63 in the study group and 5.95 鹵0.89 in the control group, and the effect of cervical dilatation in the study group was better than that in the control group. The rates of nausea and vomiting, abdominal pain, diarrhea, vaginal hemorrhage and fever in the study group were significantly lower than those in the control group (P 0.01). Conclusion Lamiken-R is more effective than misoprostol in dilating cervix before intrauterine surgery, and it is worth popularizing in clinic.
【作者單位】： 首都醫(yī)科大學(xué)附屬北京天壇醫(yī)院婦產(chǎn)科;
【分類號】：R169.42

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 徐艷萍;;宮頸擴(kuò)張棒收集袋的制作與應(yīng)用[J];齊魯護(hù)理雜志;2010年17期

2 華彩萍;宮頸擴(kuò)張棒臨床應(yīng)用286例效果分析[J];蘇州醫(yī)學(xué)院學(xué)報(bào);1997年05期

3 葉云凌;田偉芳;周亢;;國產(chǎn)親水性聚氨酯泡沫宮頸擴(kuò)張棒臨床效果[J];上海生物醫(yī)學(xué)工程;1992年01期

4 李花芝,付愛玲,馬望芝;雷夫諾爾合用一次性宮頸擴(kuò)張棒引產(chǎn)168例[J];菏澤醫(yī)專學(xué)報(bào);1994年02期

5 劉東，張玲，，劉付敏，趙瑞珍，徐冰，趙云霞;宮頸擴(kuò)張棒在初孕婦人工流產(chǎn)術(shù)前的應(yīng)用[J];泰山醫(yī)學(xué)院學(xué)報(bào);1994年02期

6 姜玉政,朱淑英;宮頸擴(kuò)張棒終止10—14周妊娠[J];醫(yī)學(xué)理論與實(shí)踐;1994年01期

7 馮雪遠(yuǎn);宮頸擴(kuò)張棒在引產(chǎn)中的應(yīng)用[J];中國計(jì)劃生育學(xué)雜志;1994年06期

8 劉忠;劉偉男;李寧;;優(yōu)美特宮頸擴(kuò)張棒用于擴(kuò)張宮頸口的臨床研究[J];中國計(jì)劃生育和婦產(chǎn)科;2014年01期

9 孫建珍;;米非司酮配伍米索前列醇及一次性宮頸擴(kuò)張棒終止12～16周妊娠的療效體會[J];右江醫(yī)學(xué);2009年05期

10 郝鳳梅;苗華艷;;宮頸擴(kuò)張棒在終止10～16周妊娠中的應(yīng)用觀察[J];中國社區(qū)醫(yī)師(醫(yī)學(xué)專業(yè));2012年01期

本文編號：1867784